|
|
| Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Your results on : IPO | IPO Synopsis |
|
|
|
| Nephrocare Health Services Ltd |
|
Registered Office:
5th Flr D Block iLabs Centre,Plot 18 Software Units Sy.#.64
,
Hyderabad
-
500081
,
Telangana
, India.
Phone :
+91 40 4240 8039 Fax:
Email : cs@nephroplus.com
Website : www.nephroplus.com
|
Initial public offering of 18,943,264 equity shares of face value of  2/- each ("equity shares") of Nephrocare Health Services Limited ("the company" or the "company" or the "issuer") for cash at a price of 460/- per equity share face value of 2/- (including a securities premium of 458/- per equity share) ("offer price") aggregating to 871.05 crores ("offer") comprising a fresh issue of 7,690,162 equity shares of face value of 2/- each aggregating to 353.41 crores ("fresh issue") and an offer for sale of 11,253,102 equity shares of face value of 2/- each ("offered shares") aggregating to 517.64 crores , comprising an offer for sale of 1,521,728 equity shares of face value of 2/- each aggregating to 70.00 crores by Investcorp Private Equity Fund II and 1,604,907 equity shares of face value of 2/- each aggregating to 73.83 crores by Healthcare Parent Limited and 147,765 equity shares of face value of 2/- each aggregating to 6.80 crores by Investcorp Growth Opportunity Fund and 2,888,911 equity shares of face value of 2/- each aggregating to 132.89 crores by Edoras Investment Holdings Pte. Ltd. ("promoter selling shareholders")
and 121,985 equity shares of face value of 2/- each aggregating to 5.61 crores by Investcorp India Private Equity Opportunity Limited and 3,089,663 equity shares
of face value of 2/- each aggregating to 142.12 crores by International Finance Coproration and 1,433,468 equity shares of face value of 2/- each aggregating to 65.94 crores by 360 One Special Opportunities Fund - Series 9 and 444,675 equity shares of face value of 2/- each aggregating to 20.46 crores by 360 One Special Opportunities Fund - Series 10 ("other selling shareholders" and together with the promoter selling shareholders, the "selling shareholders" and such offer for sale by the selling shareholders, the "offer for sale"). The offer constituted 18.88% of the post-offer paid-up equity share capital of the company. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 10-Dec-25 |
12-Dec-25 |
Rs460.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :32 Further Multiples of :32 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
325.15 |
|
| Project Financed through Current Offer |
871.05 |
|
| Post Issue Equity Share Capital |
20.07 |
|
| Issue Price |
Rs460.00 |
|
|
|
|
| |
| Projects |
|
| Capital expenditure by our Company for opening new dialysis clinics in India | General corporate purposes |
| Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company | |
|
|
|
| Promoted By |
|
| Vikram Vuppala |
| Bessemer Venture Partners Trus |
| Edoras Investment Holdings Pte |
|
|
| Registrar to the Issue |
|
| KFin Techologies Ltd |
|
|
| |
|
|
|
|
|
| |
|
|
| |
| X |
| Filing complaints on SCORES |
| Easy & Quick |
| |
| › |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
| Name |
PAN |
Address |
Mobile No. |
Email ID |
|
| › |
Benefits: |
| |
|
|
|